Throne Biotechnologies

Throne Biotechnologies Throne's Stem Cell Educator Therapy can reverse type 1 diabetes and autoimmune diseases

Stem Cell Educator Therapy is the world's leading technology for the reversal of diabetes and other autoimmune diseases. 200+ patients from more than 10 years of clinical trials in Spain, China, and the US demonstrate Stem Cell Educator Therapy's safety and efficacy.

We are honored to announce that Throne Biotechnologies is one of the awardees of "5 Best Biotech Companies to Watch" by ...
03/23/2022

We are honored to announce that Throne Biotechnologies is one of the awardees of "5 Best Biotech Companies to Watch" by the Silicon Review!

To support Throne on our journey, check out our equity Crowdfunding campaign here: https://www.startengine.com/throne-biotechnologies

We are very excited that our equity crowdfunding campaign is live on StartEngine! The Press Release of this campaign has...
03/19/2022

We are very excited that our equity crowdfunding campaign is live on StartEngine! The Press Release of this campaign has been widely published in major social media such as Time, Entrepreneur, US Weekly, Newsday, Washington Times, The Hill, Chicago Tribune, Daily Press, Reader’s Digest, Life and Style Magazine, Wall Street Business News, NBC-2, ABC-7, and etc.

Throne Biotechnologies (Throne), one of the global-leading biotech companies aiming to achieve the FDA approval on the Stem Cell Educator therapy and find a cure for type 1 diabetes, alopecia areata and other autoimmune diseases. Those interested in facilitating the clinical transition of Stem Cell Educator therapy can visit the Throne campaign page to learn more and invest on StartEngine: https://www.startengine.com/throne-Throne Biotechnologies

Throne Biotechnologies, one of the global-leading biotech companies aiming to find a cure for type 1 diabetes, announced...
03/19/2022

Throne Biotechnologies, one of the global-leading biotech companies aiming to find a cure for type 1 diabetes, announced the launch of their Regulation Crowdfunding raise to support the United States FDA-approved phase 2 clinical trials of Stem Cell Educator therapy to treat type 1 diabetes, alopecia areata and other autoimmune diseases.

"We are so excited to launch this equity crowdfunding through the platform at StartEngine," said Founder and CEO, Dr. Yong Zhao. "Throne is aiming to achieve the Practical Cure for type 1 diabetes, alopecia areata, and other autoimmune diseases through its patented technology, Stem Cell Educator therapy — a one-time, dialysis-like treatment that fundamentally 're-educates' the defective patient's immune system back to health."

Equity crowdfunding gives Throne an opportunity to raise capital from the public. Investors hold partial ownership in the company and have the opportunity to profit if the company does well. Those interested in facilitating the clinical transition of Stem Cell Educator therapy can join the company's equity crowdfunding campaign on StartEngine: https://www.startengine.com/throne-biotechnologies

We are working on something big! Stay tuned!
11/17/2021

We are working on something big! Stay tuned!

06/16/2021

WE WON!! Throne was awarded 1st place for having the most innovative technology among 49 other companies competing in the 2021 RESI Innovator’s Pitch Challenge (IPC) hosted by Life Science Nation.

04/22/2021

EXCITING ANNOUNCEMENT! Stem Cell Educator Therapy is FDA approved to begin phase II clinical trials treating COVID-19!

Similar to Throne's diabetes research, Stem Cell Educator Therapy will aim to reset and strengthen compromised immune systems while reducing mortality rates among existing COVID-19 patients.

03/22/2021

Aaron was only 13 years old when he underwent the Stem Cell Educator Therapy clinical trials in 2018. Listen to him share his experience and what life looks like for him now — two and half years later!

That's a wrap! We just finished shooting an interview with a young Stem Cell Educator Therapy recipient. Stay tuned for ...
03/01/2021

That's a wrap! We just finished shooting an interview with a young Stem Cell Educator Therapy recipient. Stay tuned for what his life with type 1 diabetes looks like now, two years after treatment!

Address

Carneys Point, NJ

Website

Alerts

Be the first to know and let us send you an email when Throne Biotechnologies posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Throne Biotechnologies:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram